Major Features of the 2021 WHO Classification of CNS Tumors
Authors:
Open Access
- 16 May 2022
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 19 (6) , 1691-1704
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS118039, R01NS102669, R01NS117104)
- National Cancer Institute (P50CA221747)
This publication has 109 references indexed in Scilit:
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factorMYBL1Proceedings of the National Academy of Sciences, 2013
- The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expressionGenes & Development, 2013
- Subgroup-specific structural variation across 1,000 medulloblastoma genomesNature, 2012
- Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancersThe Journal of Pathology, 2011
- Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohortsJournal of Negative Results in BioMedicine, 2011
- MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaNeuro-Oncology, 2009
- Chordoid Glioma: A Case Report and Molecular Characterization of Five CasesBrain Pathology, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007